Jeff Baxter
Chief Executive Officer chez VBI VACCINES INC.
Fortune : 12 225 $ au 31/03/2024
Postes actifs de Jeff Baxter
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VBI VACCINES INC. | Director/Board Member | 01/05/2016 | - |
| Chief Executive Officer | 01/05/2016 | - | |
| President | 01/05/2016 | - | |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Director/Board Member | 22/09/2009 | - |
| Chief Executive Officer | 22/09/2009 | - | |
| President | 22/09/2009 | - | |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Director/Board Member | 01/07/2014 | - |
| Chief Executive Officer | 01/07/2014 | - | |
| President | 01/07/2014 | - |
Historique de carrière de Jeff Baxter
Anciens postes connus de Jeff Baxter
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHROMADEX CORPORATION | Director/Board Member | 16/04/2015 | 04/04/2022 |
| Independent Dir/Board Member | 16/04/2015 | 04/04/2022 | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Chief Investment Officer | - | 28/02/2009 |
| Private Equity Investor | - | 28/02/2009 | |
| GSK PLC | Corporate Officer/Principal | 01/01/2002 | 01/07/2006 |
| UNILEVER PLC | Corporate Officer/Principal | - | - |
| BRITISH AMERICAN TOBACCO P.L.C. | Corporate Officer/Principal | - | - |
Formation de Jeff Baxter
| University of West London | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Royaume-Uni | 5 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectorielle
| Health Technology | 6 |
| Consumer Non-Durables | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BRITISH AMERICAN TOBACCO P.L.C. | Consumer Non-Durables |
| UNILEVER PLC | Consumer Non-Durables |
| GSK PLC | Health Technology |
| CHROMADEX CORPORATION | Health Technology |
| VBI VACCINES INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
- Bourse
- Insiders
- Jeff Baxter
- Expérience
